Irene Schilcher

QPS (Austria) — Austria

Medicine · Health Sciences

11h-index338citations31works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(10), Diabetes, Cardiovascular Risks, and Lipoproteins(6), Neuroinflammation and Neurodegeneration Mechanisms(6), Parkinson's Disease Mechanisms and Treatments(4), Lysosomal Storage Disorders Research(4)

Publications31 total

Corrigendum to “Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice” [MOLMET 85 (2024) 1–16]
Molecular Metabolism·2024· 1 citedOpen Access
Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice
Molecular Metabolism·2024· 5 citedOpen Access
Sex and genotype dependent differences in amyloid beta levels and lipid metabolism in type 2 diabetic APPxhQC transgenic mice
Alzheimer s & Dementia·2023Open Access
Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer’s disease-related blood brain barrier dysfunction and inflammation
Brain Research·2023· 33 citedOpen Access
Myopathic and neuronal pathologies of the 6 mouse model of Pompe disease
Molecular Genetics and Metabolism·2023
Motor deficits in homozygous 6 mice as model of Pompe disease
Molecular Genetics and Metabolism·2023Open Access
Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease
Molecular Psychiatry·2022· 42 citedOpen Access
Establishing a Type 2 Diabetes phenotype in APPxhQC transgenic mice expressing N‐terminally modified pGlu Aβ peptides.
Alzheimer s & Dementia·2022
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines study
Brain Communications·2022· 29 citedOpen Access
Characterization of in vivo and in vitro drug screening models for Gaucher disease based on GBA-D409V-KI mice
Molecular Genetics and Metabolism·2022
A brain proteomic signature of incipient Alzheimer’s disease in young<i>APOE</i>ε4 carriers identifies novel drug targets
Science Advances·2021· 50 citedOpen Access
Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein
Journal of Alzheimer s Disease·2021· 4 cited
Characterization of 4 L/PS-NA mice for cytokine activity and neurodegeneration
Molecular Genetics and Metabolism·2021
Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
International Journal of Molecular Sciences·2021· 12 citedOpen Access
Neurofilament‐light chain in murine models of neurodegenerative and rare diseases
Alzheimer s & Dementia·2020· 1 citedOpen Access
Inflammasome activation and reduced sTREM2 release in LPS stimulated organotypic brain slices
Alzheimer s & Dementia·2020
Bispecific tau antibodies with additional binding to C1q or alpha-synuclein
2020· 1 citedOpen Access
Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value
Frontiers in Neuroscience·2020· 59 citedOpen Access
Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease
PLoS ONE·2020· 11 citedOpen Access
Endothelial lipase increases eNOS activating capacity of high-density lipoprotein
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids·2020· 19 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Tina Loeffler(17), Birgit Hutter‐Paier(14), Stefanie Flunkert(11), Saša Frank(9), Manuela Prokesch(8), Joerg Neddens(7), Gunther Marsche(6), Joshua Adekunle Babalola(5), Gerd Leitinger(5), Gerald Höefler(5), Anika Stracke(4), Achim Lass(4), Snježana Radulović(4), Seth Hallström(4), Thomas O. Eichmann(4), Dagmar Kratky(4), Ewald Auer(4), Vijay R. Varma(3), Madhav Thambisetty(3), Jelena Tadić(3)